| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.09 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |